InvestorsHub Logo
Followers 14
Posts 817
Boards Moderated 0
Alias Born 02/24/2010

Re: JPsooner post# 224157

Friday, 04/13/2018 3:35:19 PM

Friday, April 13, 2018 3:35:19 PM

Post# of 403593
Hello JPsooner, partnership sure is a possibility but why wind down all the clinical trials just to partner one or partner one drug in one indication? With a 70 million market cap. and limited funding especially for phase 3 trials, what would be the motivation for big pharma to partner with Innovation when it would make a whole lot more sense for them to acquire the whole portfolio?

Now that I think about I don't believe the company has given any guidance on any future trials for their drugs. Sure its perhaps its too early for B-OM and Prurisol but what about Kevetrin, B-UP/UC and B ABX.

Given their age and stock holding in the company I don't see Dr. Menon and Leo riding any of these drugs through a phase 3 and a big meeting with the FDA, partner or not. And they cannot really sell their stock in the company until the company is no more.

I have been invested in the is company for 11 years and something is clearly different now. For my own personal investment decisions they need to partner or sell with in ~6 months...

And all of that is IMO